PharmaShots | Incisive News in 3 Shots

Subscribe Now

EMA

Celltrion Reports the MAA Submission to the MFDS Korea for CT-P47 (biosimilar, tocilizumab) to Treat Various Indications

Celltrion Reports the MAA Submission to the MFDS Korea for CT-P47 (biosimilar, tocilizumab) to Treat Various Indications 

February 29, 2024

BMS Reports the US FDA Acceptance of sBLA for Priority Review and EMA Validation of Application for Reblozyl (luspatercept-aamt) as 1L Treatment of Anemia

BMS Reports the US FDA Acceptance of sBLA for Priority Review and EMA Validation of Application for Reblozyl (luspatercept-aamt) a...

May 1, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us